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Introduction: Osteopontin (OPN) is a multifunctional protein with an
important but poorly understood role in non-small cell lung cancer
(NSCLC) pathogenesis. Moreover, the role of the three known mRNA
isoforms (OPNa, OPNb, and OPNc) has not been reported. We
hypothesize that OPN isoforms play different roles in determining the
metastatic potential of NSCLC.
Methods: We amplified mRNA for each OPN isoform in NSCLC
tumors and matched normal lung. The functional impact of each
isoform was evaluated by transfecting cDNA plasmids specific to each
isoform into NSCLC cell lines and comparing behavior to empty vector
controls in scratch closure, cell proliferation, soft-agar colony forma-
tion, and Matrigel invasion assays. Gene array was used to evaluate
differences in downstream targets and was compared with a panel of
markers for epithelial-mesenchymal transition (EMT).
Results: OPNa expression was increased in 91% of NSCLC tumors
compared with matched lung. OPNa overexpression significantly in-
creased activity in scratch closure, proliferation, soft-agar colony for-
mation, and Matrigel invasion assays compared with controls in all cell
lines. OPNb overexpression produced a less significant modulation of
function. OPNc overexpression significantly decreased activity in pro-
liferation, colony formation, and invasion assays compared with con-
trols. Expression arrays revealed an increase in EMT with OPNa
overexpression but not OPNc. Differences were validated by quantita-
tive reverse transcriptase-polymerase chain reaction.
Conclusions: Overexpression of the individual OPN isoforms in
NSCLC results in divergent functional phenotypes. OPNa produced an
aggressive phenotype, whereas OPNc produced a more indolent phe-
notype. Exon 4, which is transcribed inOPNa but absent inOPNc, may
be central to this phenomenon and could serve as a target for isoform-
specific inhibition of OPN in NSCLC.
Key Words: Osteopontin, Non-small cell lung cancer, mRNA
isoforms, Tumor progression, Epithelial-mesenchymal transition.
(J Thorac Oncol. 2010;5: 1516–1523)
Osteopontin (OPN) is a multifunctional protein identifiedin a remarkable range of normal and pathologic con-
texts. It plays a key role in the mediation of immune cell
recruitment, wound healing, and tissue remodeling.1,2 OPN’s
diverse biologic functions involve cell adhesion, migra-
tion, and invasion, which are associated with its two highly
preserved central binding domains, the arginine-glycine-
aspartic acid (RGD) and serine-valine-valine-tyrosine-gly-
cine-leucine-arginine [SVVYGLR] sequences. OPN is a li-
gand for the v integrins and mediates adhesive cell-matrix
interactions and signal transduction pathways through bind-
ing at these locations.
The importance of OPN in tumor dissemination is
highlighted in gene transfer experiments, where transfec-
tion of OPN increases the malignant phenotype4 and OPN
knock out with antisense oligonucleotides decreases ma-
lignant potential.5,6 Structural heterogeneity may be re-
sponsible for varying functions of OPN from different
cellular sources. Alternative gene splicing may provide an
explanation for its diversity. Three distinct OPN cDNA
isoforms have been identified in humans, but little is known
about their function.7 Osteopontin-a (OPNa) represents the
full-length cDNA, whereas osteopontin-b (OPNb) has a de-
letion at exon 5, and osteopontin-c (OPNc) has a deletion at
exon 4 (Figure 1).8
OPN is overexpressed by immunohistochemistry in non-
small cell lung cancer (NSCLC) tumors compared with sur-
rounding normal lung.9 NSCLC cell lines, which overexpress
OPN, have increased in vitro migration and invasion.9 Elevated
tumor OPN levels are also associated with increased stage,
lymph node involvement and poor long-term survival.9–11
These data indicate an important role for OPN in determining
the metastatic potential in NSCLC; however, reports of OPN
expression in clinical NSCLC samples and tumor models
have not reported which isoforms are expressed. We hypoth-
esize that the individual isoforms are not equally expressed in
NSCLC tumors and have significantly different roles in
determining the metastatic potential in NSCLC through al-
teration in downstream gene targets.
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MATERIALS AND METHODS
Tumor Specimens and RNA Isolation
We evaluated mRNA expression of the OPN isoforms in
43 resected NSCLC tumors and matched normal lung. Tissue
specimens were collected from consented patients undergoing
resection of NSCLC at Wayne State University from 1998 to
2005, with institutional review board approval. The specimens
were transferred to New York University School of Medicine
under a cooperative materials transfer agreement and the NYU
Institutional Review Board granted approval for use of deiden-
tified specimens for biomarker discoveries. Tumor and normal
tissues were homogenized, and mRNA was isolated using
RNEasy mini kit from Qiagen (QIAGEN, Valencia, CA).
NSCLC Cell Lines
NSCLC cell lines, H358, A549, and H460, were obtained
from American Type Tissue Collection (Manassas, VA) and
maintained in culture in Dulbecco’s Modified Eagle Medium
(DMEM) (Invitrogen, Grand Island, NY) with 10% fetal bovine
serum (FBS) (Invitrogen, Grand Island, NY) at 37° and 5%
CO2. Prior evaluation had determined that H358 had minimal
native OPN mRNA expression and protein secretion, whereas
A549 and H460 had high native mRNA expression and protein
secretion of OPNa and OPNb and high protein secretion.12
Reverse Transcriptase-Polymerase Chain
Reaction Primers
Reverse transcriptase-polymerase chain reaction (RT-PCR)
primers were designed based on the three NCBI GenBank
sequences to be inclusive of the regions of exon 4 and exon
5 at the N-terminus, which are deleted from OPNc and
OPNb, respectively. The resulting primers (Table 1) amplify
a 305 bp product from OPNa, a 263 bp product from OPNb,
and a 224 bp product from OPNc in a single reaction, which
were separated by electrophoresis (Figure 1). RT-PCR am-
plification was carried out using the Invitrogen PCR buffer
system (Invitrogen, Carlsbad, CA). The reactions were per-
formed with denaturing for 15 seconds at 94°, annealing for
30 seconds at 58°, elongation for 30 seconds at 70° for 40
cycles, and final extension at 72° for 5 minutes. RT-PCR
products were analyzed by Tris-acetate ethylenediaminetet-
raacetic acid agarose (2.5% wt/vol) gel electrophoresis. The
amplification of peptidal prolyl isomerase A served as con-
trols for equal loading and integrity of RT-PCR and all
reactions.
OPN Isoform Expression Constructs
and Transfection
pCMV2-based plasmid constructs expressing OPNa
(NM_001040058),OPNb (NM_00058),OPNc (NM_001040060),
and empty vector for control (Origene, Rockville, MD) were
complexed with lipofectamine 2000 (Invitrogen, Carlsbad,
CA) for transfection into NSCLC cell lines. Proof of trans-
fection was evaluated by RT-PCR from a pooled population
of cells. Pooled populations of transfected cells were used in
scratch closure, cell proliferation, soft-agar colony formation,
and Matrigel invasion assays. Comparisons were made be-
tween cells transfected with each isoform and empty cyto-
megalovirus plasmid vector. Assays were performed in trip-
licate, and the data were collected independently and
expressed as mean SE. A two-sided Student’s t test was
used to evaluate data, and differences were regarded as
significant at p  0.05.
Scratch Closure Assay
Two  105 transfected cells were plated in 3 ml of
serum-free DMEM in six-well plates. A scratch was made
through the bottom of the plate using a 1-ml sterile pipette tip
24 hours later. Plates were washed with phosphate buffered
saline (PBS) and the undersides of plates were marked. The
scratch width was measured at six locations. Plates were
incubated for 24 hours and scratch width measured at the
FIGURE 1. Three human cDNA splice variants of osteopon-
tin (OPN) and GenBank accession numbers. OPNa has six
translated exons, whereas OPNb has a deletion of exon 5,
and OPNc has a deletion of exon 4. The PCR primers amplify
the region of variability between the three isoforms shown
by the arrows. The isoforms can be discriminated in a single-
reaction RT-PCR localized to that region.
TABLE 1. Primers Used for Semiquantitative PCR Analysis
Gene Forward (5-3) Reverse (5-3)
Osteopontin TTGCAGTGATTTGCTTTTGC GTCAATGGAGTCCTGGCTGT
PPIA TCTGAGCACTGGAGAGAAAGG GGAAAACATGGAACCCAAAGG
Snail-2 CATGCCATTGAAGCTGAAAA GCAGTGAGGGCAAGAAAAAG
TGF receptorb-1 ACCTGAACCCGTGTTGCTCT CCGGTAGTGAACCCGTTGAT
N-Cadherin GCGTCTGTAGAGGCTTCTGG ACTGCCACTTGCCACTTTTC
Vimentin CGAAAACACCCTGCAATCTT TTGGCAGCCACACTTTCATA
Desmoplakin CGTGATCACCGACCAGAAC GGGCAAAACACTCATCCAAT
Cytokeratin-20 TGAAGAGCTGCGAAGTCAGA CAGCATCAACCTCCACATTG
E-Cadherin CAGGTCTCCTCTTGGCTCTG GGCGTAGACCAAGAAATGGA
PPIA, peptidal prolyl isomerase A; TGF, transforming growth factor.
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same six points. Closure was calculated as a percent of initial
scratch width.
Cell Proliferation Assay
Three 103 transfected cells in 100 l of DMEM/10%
FBS were plated in 96-well flat bottom plates in six replicates
and incubated for 48 hours. Twenty microliters of CellTiter-
Blue reagent (Promega, Madison, WI) was added to each well
and incubated for 1 hour. Optical density was measured at
560/590 using the Universal Reader Victor3 (PerkinElmer,
Waltham, MA) and compared with standard curve derived for
each cell line.
Soft-Agar Colony Formation
Base agars were made by combing equal volumes of
1% agarose and 2  DMEM/10% FBS, both at 40°. Warm
base agar (1.5 ml) was plated into six-well plates and allowed
to polymerize. The top agar was produced by combing equal
volumes 5  103 transfected cells/ml in 1  DMEM/10%
FBS with warm 0.7% agarose. Two milliliters of the agarose
cell mixture was placed on top of each base coat. Plates were
incubated at 37°, 5% CO2. At 21 days, colonies were stained
with 0.5 ml of Crystal violet and counted under a dissecting
microscope.
Matrigel Invasion Assay
The BD Biocoat Matrigel invasion chambers were used
in accordance with the manufacturer’s protocol (BD Sci-
ences, Franklin Lakes, NJ). The 1  105 transfected cells
were seeded onto 8-M pore polycarbonate membrane in-
serts coated with a thin layer Matrigel basement membrane
matrix diluted 1:100 in PBS. Plates were incubated for 48
hours. Cells that migrated through the Matrigel to the lower
surface were fixed and stained with Giemsa solution and
counted under microscope at 10 amplification. Ten fields
from each membrane were counted.
Gene Expression Analysis
mRNA extracted from the pooled population of trans-
fected cells used in the functional assays was analyzed using
Affymetrix U133 plus-2 chips (Affymetrix Inc., Santa Clara,
CA). Each probe was scanned twice (Hewlett-Packard Gene
Array Scanner), the images overlaid, and the average inten-
sities of each probe compiled and converted into expression
file format using Affymetrix Gene Chip Operating System.
We evaluated gene expression profiles in the A549 cell line
with overexpression of OPNa and OPNc isoforms and empty
vector controls in duplicate. Raw GeneChip data were nor-
malized at the probe level using the robust multichip average
algorithm13 and filtered using Genespring 7.2 (Aligent Tech-
nologies, Palo Alto, CA). The differentially abundant mRNA
between experimental cell lines and controls was filtered
using an intersection of t test results with p value of 0.05 and
false discovery rate set at 5%. Array results were compared
against a panel of common downstream markers for epithe-
lial-mesenchymal transition (EMT) to correlate functional
results with downstream gene pathways.14 RT-PCR was per-
formed using parameters described above to validate expres-
sion of Snail-2, TGFb1-r, N-cadherin, vimentin, desmo-
plakin, cytokeratin-20, and e-cadherin. Primers are listed in
Table 1.
OPN Silencing with sh-RNA
sh-RNA plasmid 5-GACCTGCCAGCAACCGAAG-3
(Geneocopoeia, Rockville, MD) was complexed with lipo-
fectamine 2000 (Invitrogen, Carlsbad, CA) for transfection into
NSCLC cell lines. Proof of knock down was evaluated by
RT-PCR from a pooled population of cells.
Real-Time Quantitative PCR Analysis
The semiquantitative expression levels were validated
with quantitative PCR in four targets: TGFb1-r, N-cadherin,
FIGURE 2. Osteopontin (OPN) mRNA expression from non-small cell lung cancer (NSCLC) specimens (T) and paired normal
lung (N) using primers which amplify each of the three OPN isoforms. OPN was overexpressed in 39 of 43 (90.7%) of NSCLC
specimens compared with matched normal lung and in all but specimen 2 shown here. OPNa is the dominant isoform ex-
pressed in all the tumor samples; OPNc was detected in normal samples but in none of the tumor tissues.
TABLE 2. Primers Used for Quantitative PCR Analysis
Gene Forward (5-3) Reverse (5-3)
-actin GATGCAGAAGGAGATCACTGC CGATCCACACGGAGTACTTG
TGF receptor-1 CCTACATTTGGAGCCTGGAC CCGGGTTATGCTGGTTGTA
N-Cadherin CTGGAGACATTGGGGACTTC AGTCATATGGTGGAGCTGTGG
Desmoplakin GGAAATTGAGAAATTCCAAAAGC GGCTCTCTCTTTCCTGTACCA
Cytokeratin-20 TCAGTTAAGCACCCTGGAAGA CGACCTTGCCATCCACTACT
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FIGURE 3. Bar graft depiction of results from functional assays with overexpression of the individual osteopontin (OPN) isoforms
in non-small cell lung cancer (NSCLC) cell lines. H358 (low native OPN expression) and A549 and H460 (high native OPN expres-
sion), transfected with empty vector for control or the individual OPN isoforms; stars denote significant differences between experi-
mental cell lines and controls. A, Scratch closure: overexpression of OPNa caused significant increase in percent closure at 24 hours
compared with controls. OPNb overexpression had a less significant increase, and OPNc had no impact compared with controls.
B, Cell proliferation assay: OPNa overexpression resulted in a significant increase in cell numbers at 24 hours in all cell lines, OPNb
overexpression had no impact compared with controls, and OPNc resulted in a significant decrease in cell number compared with
controls. C, Soft-agar colony formation assay: OPNa overexpression resulted in a significant increase in the size and numbers of col-
onies at 21 days in all cell lines, OPNb overexpression had no impact compared with controls in A549 but resulted in a significant
increase in H358 and a significant decrease in the H460 cell lines, whereas OPNc overexpression resulted in a significant decrease in
size and number of colonies in all cell lines compared with controls. D, Matrigel invasion assay: OPNa overexpression resulted in a
significant increase in invasion at 48 hours in all cell lines compared with controls, OPNb overexpression had no impact compared
with controls in any of the cell lines, whereas OPNc overexpression resulted in a significant decrease in invasion in all cell lines com-
pared with controls. E, Matrigel invasion assay normalized to cell number due to proliferation differences: OPNa expression signifi-
cantly increased invasion at 48 hours in all cell lines even after normalization for increased rates of proliferation, whereas OPNb had
no impact and OPNc significantly decreases invasion despite normalization for decreased proliferation compared with controls.
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desmoplakin, and cytokeratin-20. Super Script III first strand
synthesis super mix (Invitrogen, Carlsbad, CA) was used to
synthesize first strand cDNA. PCR was performed using
7900HT Fast Real-Time PCR System (Applied Biosystems,
Carlsbad, CA). Samples were assayed in 10-l reaction
mixture containing 2-l cDNA, 0.5 l of 5 M gene-specific
primers (Table 2), 5 l of 2 X SYBR green master mixes, and
2 l of molecular grade H2O. Beta actin was used as a
normalization control. The amplifications were performed for
40 cycles with annealing at 60°C for 1 minute. Samples were
run in triplicates including negative controls. Relative quan-
tification (2CT method) was performed to determine the
change in gene expression levels.15
RESULTS
OPN mRNA Expression is Increased in 91%
NSCLC Tumors
OPN was overexpressed in the NSCLC tumors com-
pared with the matched normal lung in 39 of 43 pairs
(90.7%), and the dominant isoform expressed in all tumor
samples was OPNa (Figure 2). OPNc expression was de-
tected in normal lung but not in any of the tumor samples.
The OPNa PCR products from NSCLC tumor specimens
were sequenced and match the OPNa NCBI GenBank se-
quence NM_001040060.
Functional Heterogeneity with Individual OPN
Isoform Overexpression in NSCLC Cell Lines
In all three cell lines, OPNa overexpression significantly
increased activity in scratch closure and proliferation assays at
24 hours. OPNa overexpression significantly increased the size
and number of colonies in soft agar and significantly increased
the rate of invasion through Matrigel compared with controls
(Figures 3A–D). Overexpression of OPNb produced a less
significant modulation of function compared with OPNa in all
assays and all cell lines (Figures 3A–D). OPNc overexpression
had no impact compared with control in scratch closure (Figure
3A) but significantly decreased activity in proliferation, soft-agar
colony formation, andMatrigel invasion compared with controls
(Figures 3B, C). When Matrigel invasion results were normal-
ized to differential rates of proliferation, the differences re-
mained significant (Figure 3E).
OPNa Overexpression Induces EMT
We examined gene expression data from the A549 cell
line with OPNa and OPNc overexpression compared with
cytomegalovirus plasmid controls and compared it with a stan-
FIGURE 4. Waterfall depiction of changes in
relative expression of a series of gene products
associated with epithelial-mesenchymal transi-
tion (EMT) with overexpression of osteopontin
(OPN) isoforms compared with controls. A,
Overexpression of OPNa results in a pattern of
gene regulation consistent with activation of
EMT pathways. B, Overexpression of OPNc pro-
duced a pattern of gene expression far less
consistent with EMT.
Goparaju et al. Journal of Thoracic Oncology • Volume 5, Number 10, October 2010
Copyright © 2010 by the International Association for the Study of Lung Cancer1520
dard panel of makers associated with EMT.16 OPNa overex-
pression resulted in a relative increase in expression of matrix
metalloproteinase (MMP)-2, Snail-1, Snail-2, TGFb1-r,
MMP-9, N-cadherin, ILK, vimentin, SOX-8, and SOX-9, and a
relative decrease in the expression of cytokeratin 18 and 20,
desmoplakin, and E-cadherin, all consistent with activation of
EMT pathways (Figure 4A). We noted no significant change in
expression of Twist, goosecoid, FoxC-2, Sox 10, or MMP-3.
OPNc overexpression resulted in relative increase in expression
of MMP-2, MMP-9, and Snail-1 but a relative decrease in
Snail-2, TGFb1-r, N-cadherin, ILK, vimentin, Sox-8, Sox-9, and
fibronectin. Cytokeratin 18 and occludin were downregulated,
but cytokeratin 20 and desmoplakin were upregulated, overall a
far less consistent picture for EMT activation with OPNc over-
expression. Relative differences in expression of the markers
betweenOPNa andOPNc overexpressing cell lines and controls
were analyzed by semiquantitative RT-PCR and were similar
across all three cell lines (Figure 5).
Changes in expression of four markers were vali-
dated by quantitative PCR. Computed tomography (CT)-
FIGURE 5. Semiquantitative PCR analysis of
differences in relative expression in series of
epithelial-mesenchymal transition (EMT) mark-
ers discovered in gene arrays. Expression
changes are validated in three non-small cell
lung cancer (NSCLC) cell lines, each with over-
expression of the individual osteopontin (OPN)
isoforms. OPNa overexpression resulted in
downstream changes consistent with activation
of EMT pathways, demonstrated here with rel-
ative increase in expression of Snail-2, TGFb1-r,
N-cadherin, and vimentin and downregulation
in desmoplakin, e-cadherin, and cytokeratin-20
in all three cell lines. The pattern of expression
resulting from overexpression of OPNb and
OPNc are not reflective of EMT pathways.
FIGURE 6. Quantitative PCR results validating differential in expression of TGFb1-r and N-cadherin. A, Bar graphs depict relative
changes in mRNA levels of TGFb1-r and N-cadherin normalized to controls. Overexpression of osteopontin OPNa resulted in a signif-
icant increase in mRNA levels of both markers in each non-small cell lung cancer (NSCLC) cell line, whereas OPNc overexpression
resulted in significant decrease in the mRNA levels in each cell line. B, sh-RNA inhibition of native OPN expression had minimal im-
pact on mRNA level of TGFb1-r and N-cadherin in H358, but significantly decreased the levels in A549 and H460.
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values for TGFb1-r and N-cadherin were higher in H358
controls than in H460 and A549, and were significantly
decreased in all three cell lines with the overexpression of
OPNa and increased with overexpression of OPNc, con-
sistent with gene array expression data (Figure 6A). Base-
line CT-values for desmoplakin and cytokeratin-20 were
lower in the H358 cell line than in H460 and A549, and
were significantly increased with OPNa expression and
decreased with OPNc expression across all cell lines
(Figure 7A).
Inhibition of native OPN expression by sh-RNA re-
sulted in minimal changes in mRNA levels of TGFb1-r,
N-cadherin, and desmoplakin in H358, the cell line with
minimal native OPNa expression, but resulted in a significant
decrease in TGFb1-r and N-cadherin mRNA levels and
significantly increased desmoplakin and cytokeratin-20 in the
A549 and H460 cell lines, each with high native OPNa
expression (Figures 6B and 7B).
DISCUSSION
Lung cancer is the world’s leading cause of cancer
death. A better understanding of the molecular pathogenesis
is necessary to detect new biomarkers, develop new treatment
strategies, and improve survival. OPN is a ubiquitous protein
whose functions center on cell migration and invasion. Hu et
al.9 noted an association between OPN overexpression and
aggressive NSCLC phenotypes with increased in vitro cell
invasion. The data presented here are unique because it
identifies a single-putative isoform, which is uniquely over-
expressed and tied to malignant behavior. OPNa, the full
length isoform, produced a more aggressive phenotype with
increased migration, proliferation, anchorage independent
growth, and invasion when overexpressed. In contrast, OPNc,
which is defined by the deletion of exon 4, confers the
opposite effect when overexpressed in NSCLC cell lines,
decreasing proliferation, anchorage independent growth, and
invasion compared with controls. Importantly, OPNa is the
isoform preferentially upregulated in NSCLC tumors (Figure
2) and cell lines.12 This rate of overexpression is consistent
with others who have noted increased OPN mRNA expres-
sion in 80% of NSCLC tumors compared with normal lung17
and recognize OPN as one of the most consistently overex-
pressed genes in NSCLC cDNA libraries.18
Heterogeneous expression of the OPN isoforms has
been documented in human glioma and breast cancer
cells.8,19 In breast cancer, OPNc is a unique marker for
malignant tissue, which is not seen in normal breast tissue,
and correlates with tumor grade.20 A varied role for the
isoforms is identified in breast cancer, where in vitro
experiments demonstrate enhanced anchorage independent
growth and a lack of calcium-dependant aggregation and
cell adhesion with the incorporation of OPNc but not
OPNa.21 This supports the hypothesis that the isoforms
have differing functions in malignancy.
FIGURE 7. Quantitative PCR results validating differential in expression of desmoplakin and cytokeratin-20. A, Bar graphs de-
pict relative changes in mRNA levels of desmoplakin and cytokeratin-20 normalized to controls. Overexpression of osteopontin
OPNa resulted in a significant decrease in mRNA levels of both markers in each cell line, whereas OPNc overexpression re-
sulted in significant increase in the mRNA levels in each cell line. B, sh-RNA inhibition of native OPN expression had minimal
impact on mRNA level of desmoplakin and cytokeratin-20 in H358 but significantly increased the levels in A549 and H460.
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This work also correlates the functional findings with
gene array data where an increase in EMT markers was noted
with OPNa overexpression but not OPNc. EMT enables
benign tumor cells the capacity to infiltrate surrounding tissue
and ultimately metastasize to distant sites and is implicated in
the conversion of early tumors to invasive malignancies.22
The molecular basis of EMT involves changes in the expres-
sion, distribution, and function of multiple proteins including
integrins, vimentin, MMPs, and cadherins.14
The cadherins are a family of calcium-dependent cell
adhesion molecules critical to the development and main-
tenance of epithelial architecture. E-cadherin maintains
cell to cell interactions, and its loss is a hallmark for metastatic
progression of solid tumors.14 Conversely, N-cadherin stimu-
lates tumor invasiveness and progression by providing tumor
cells the ability to permeate tissues. It promotes adhesive inter-
actions with host stroma and endothelium that facilitates tumor
dissemination.23 Overexpression of OPNa in NSCLC cell lines
resulted in a classic switch in cadherin class: loss of e-cadherin
and gain of N-cadherin, which has been closely linked to both
EMT and tumor progression.24 Knockdown of endogenous
OPNa by sh-RNA reversed the cadherin switch, increasing
expression of E-cadherin and decreasing N-cadherin. Overex-
pression of OPNc did not produce the same classic downstream
pattern consistent with increased EMT and malignant potential.
The observations that OPNa overexpression in
NSCLC increased malignant behavior in vitro and EMT
pathways compared with controls coupled with the finding
of a decrease in the same properties with OPNc overex-
pression is fortuitous because the only difference between
OPNa and OPNc is the transcription of exon 4, a 27-amino
acid sequence in the amino terminus of the protein. Al-
though two centrally preserved integrin binding domains
(RGD and SVVYGLR) of OPN is essential to its activity,
these data implicate exon 4 as an important regulator in the
malignant potential of NSCLC. This region should contain
the structure that dictates function relevant to at least some
of the demonstrated malignant properties conferred by
OPNa in NSCLC. The gene array data provide important
information on downstream gene targets and molecular
pathways, which are responsible for this differential func-
tion. Targeted small molecules and monoclonal antibody
therapies are highly successful treatment programs in on-
cology, and the structural similarities between the isoforms
may make OPN an ideal target for such treatment strate-
gies in NSCLC.
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